Cargando…
Can fecal calprotectin better stratify Crohn’s disease activity index?
BACKGROUND: Crohn’s disease (CD) activity index (CDAI) is still widely used for monitoring clinical activity in CD patients, but is of little value as indicator of persistent inflammation in symptomless patients. Fecal calprotectin levels ≥150 µg/g are strongly indicative of endoscopically and/or hi...
Autores principales: | Scaioli, Eleonora, Cardamone, Carla, Scagliarini, Michele, Zagari, Rocco Maurizio, Bazzoli, Franco, Belluzzi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367215/ https://www.ncbi.nlm.nih.gov/pubmed/25831217 |
Ejemplares similares
-
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial
por: Scaioli, Eleonora, et al.
Publicado: (2019) -
Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease
por: Fabi, Marianna, et al.
Publicado: (2022) -
Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease
por: Kennedy, Nicholas A., et al.
Publicado: (2019) -
The Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid
por: Scaioli, Eleonora, et al.
Publicado: (2015) -
Attitudes of Crohn’s Disease Patients: Infodemiology Case Study and Sentiment Analysis of Facebook and Twitter Posts
por: Roccetti, Marco, et al.
Publicado: (2017)